David Inwards

David Inwards

UNVERIFIED PROFILE

Are you David Inwards?   Register this Author

Register author
David Inwards

David Inwards

Publications by authors named "David Inwards"

Are you David Inwards?   Register this Author

100Publications

3455Reads

33Profile Views

Acalabrutinib for mantle cell lymphoma.

Blood 2019 Jun 9;133(24):2570-2574. Epub 2019 Apr 9.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood.2019852368DOI Listing
June 2019

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis.

Leuk Res 2019 Jun 4;81:1-9. Epub 2019 Apr 4.

Division of Hematology, Department of Medicine, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, United States; Department of Medical Oncology, Mayo Clinic 200 First St. SW, Rochester, MN, 55905.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.03.009DOI Listing
June 2019

Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials.

J Clin Oncol 2018 06 19;36(16):1603-1610. Epub 2018 Apr 19.

Matthew J. Maurer, Thomas M. Habermann, Carrie A. Thompson, Cristine Allmer, Patrick B. Johnston, Ivana N. Micallef, David J. Inwards, William R. Macon, Andrew L. Feldman, Susan L. Slager, Stephen M. Ansell, James R. Cerhan, Thomas E. Witzig, and Grzegorz S. Nowakowski, Mayo Clinic, Rochester, MN; Hervé Ghesquières and Gilles A. Salles, Université Claude Bernard, Lyon; Jean-Philippe Jais, Richard Delarue, Thierry J. Molina, Hopital Necker, Paris; Corinne Haioun, Groupe Hospitalier Mondor, Créteil; Frederic Peyrade, Centre Antoine Lacassagne, Nice; Olivier Fitoussi, Polyclinique Bordeaux Nord-Aquitaine, Bordeaux; Hervé Tilly, Centre de lutte Contre le Cancer Henri Becquerel, Rouen, France; Brian K. Link, Umar Farooq, Sergei Syrbu, and George J. Weiner, University of Iowa, Iowa City, IA; and Nicolas Ketterer, Clinique Bois-Cerf, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.5198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978469PMC
June 2018

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma.

Biol Blood Marrow Transplant 2016 06 27;22(6):1017-1023. Epub 2016 Jan 27.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.01.024DOI Listing
June 2016

Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.

Leuk Lymphoma 2015 Feb 27;56(2):434-9. Epub 2014 Jun 27.

Department of Emergency Medicine and the Center for Health Equity and Quality Research, University of Florida Jacksonville , Jacksonville, FL , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.916803DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666508PMC
February 2015

Lenalidomide combined with R-CHOP overcomes negative prognostic impact of non-germinal center B-cell phenotype in newly diagnosed diffuse large B-Cell lymphoma: a phase II study.

J Clin Oncol 2015 Jan 18;33(3):251-7. Epub 2014 Aug 18.

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon, Garth D. Nelson, Carrie A. Thompson, David J. Inwards, Ivana N. Micallef, Patrick B. Johnston, Luis F. Porrata, Stephen M. Ansell, Thomas M. Habermann, and Thomas E. Witzig, Mayo Clinic, Rochester, MN; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC, Canada; Craig B. Reeder, Mayo Clinic, Scottsdale, AZ; and James M. Foran and Candido E. Rivera, Mayo Clinic, Jacksonville, FL.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/08/14/JCO.2014.55
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.55.5714
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.55.5714DOI Listing
January 2015

Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma.

Biol Blood Marrow Transplant 2014 Nov 17;20(11):1804-12. Epub 2014 Jul 17.

Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.07.012DOI Listing
November 2014

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.

J Clin Oncol 2014 Nov 29;32(31):3506-12. Epub 2014 Sep 29.

Carrie A. Thompson, Matthew J. Maurer, James R. Cerhan, Stephen M. Ansell, David J. Inwards, Patrick B. Johnston, William R. Macon, Ivana N. Micallef, Grzegorz S. Nowakowski, Luis F. Porrata, Thomas E. Witzig, Thomas M. Habermann, Mayo Clinic, Rochester, MN; Herve Ghesquieres, Pierre Biron, Catherine Chassagne-Clément, Thérèse Gargi, Emmanuelle Nicolas-Virelizier, Marie Peix, Catherine Sebban, Centre Leon Berard, University of Lyon, Lyon, France; George J. Weiner and Brian K. Link, University of Iowa, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.7561DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209102PMC
November 2014

Spontaneous complete remission of angioimmunoblastic T-cell lymphoma.

Proc (Bayl Univ Med Cent) 2014 Jul;27(3):242-5

Department of Medicine (Humeniuk, Liang), Division of Hematopathology (Howard), and Division of Hematology (Inwards), Mayo Clinic, Rochester, Minnesota.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059581PMC
http://dx.doi.org/10.1080/08998280.2014.11929126DOI Listing
July 2014

Active idiotypic vaccination versus control immunotherapy for follicular lymphoma.

J Clin Oncol 2014 Jun 5;32(17):1797-803. Epub 2014 May 5.

Ronald Levy, Andrew J. Gentles, Chih Long Liu, Robert Tibshirani, and Ash A. Alizadeh, Stanford University Medical Center, Palo Alto; Christos E. Emmanouilides and John M. Timmerman, University of California Los Angeles Medical Center, Los Angeles; Lori A. Kunkel, Diane E. Ingolia, and Dan W. Denney Jr, Genitope, Fremont, CA; Kristen N. Ganjoo and Michael J. Robertson, Indiana University Medical Center, Indianapolis, IN; John P. Leonard, Weill Medical College of Cornell University, New York, NY; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Ian W. Flinn and Richard F. Ambinder, Johns Hopkins University Oncology Center, Baltimore, MD; Joseph M. Connors, British Columbia Cancer Agency Centre for Lymphoid Cancer, Vancouver, British Columbia; Neil L. Berinstein, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario; Andrew R. Belch, Cross Cancer Institute, Edmonton, Alberta, Canada; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; Craig Nichols, Oregon Health Science University, Portland, OR; Stephanie A. Gregory, Rush University Medical Center, Chicago, IL; Brian K. Link, University of Iowa Hospitals and Clinics, Iowa City, IA; David J. Inwards, Mayo Clinic, Rochester, MN; Arnold S. Freedman, Dana-Farber Cancer Institute, Boston, MA; and Jeffrey V. Matous, Rocky Mountain Cancer Centers, Denver, CO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.43.9273DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039868PMC
June 2014

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.

J Clin Oncol 2014 Feb 16;32(4):273-81. Epub 2013 Dec 16.

Timothy S. Fenske and Mehdi Hamadani, Medical College of Wisconsin; Mei-Jie Zhang, Jeanette Carreras, and Parameswaran N. Hari, Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI; Ernesto Ayala, H. Lee Moffitt Cancer Center and Research Institute, Tampa; Baldeep M. Wirk, Shands Healthcare and University of Florida, Gainesville, FL; Linda J. Burns, University of Minnesota Medical Center, Fairview, Minneapolis; David J. Inwards, Mayo Clinic Rochester, Rochester, MN; Amanda Cashen, Barnes Jewish Hospital, Washington University School of Medicine, St. Louis, MO; Luciano J. Costa, Medical University of South Carolina, Charleston, SC; César O. Freytes, South Texas Veterans Health Care System and University of Texas Health Science Center, San Antonio, TX; Robert P. Gale, Imperial College; Silvia Montoto, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom; Leona A. Holmberg and David G. Maloney, Fred Hutchinson Cancer Research Center, Seattle, WA; Hillard M. Lazarus, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH; Richard T. Maziarz, Oregon Health and Science University, Portland, OR; Reinhold Munker, Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA; Miguel-Angel Perales, Memorial Sloan-Kettering Cancer Center, New York, NY; David A. Rizzieri, Duke University Medical Center, Durham, NC; Harry C. Schouten, Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; Sonali M. Smith, University of Chicago Hospitals, Chicago, IL; Edmund K. Waller, Emory University Hospital, Atlanta, GA; and Ginna G. Laport, Stanford Hospital and Clinics, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.49.2454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3897255PMC
February 2014

Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the University of Iowa/MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource.

J Clin Oncol 2013 Sep 29;31(26):3272-8. Epub 2013 Jul 29.

Brian K. Link, Sergei I. Syrbu, University of Iowa College of Medicine, Iowa City, IA; and Matthew J. Maurer, Grzegorz S. Nowakowski, Stephen M. Ansell, William R. Macon, Susan L. Slager, Carrie A. Thompson, David J. Inwards, Patrick B. Johnston, Joseph P. Colgan, Thomas E. Witzig, Thomas M. Habermann, and James R. Cerhan, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.3990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757293PMC
September 2013

Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma.

Muscle Nerve 2012 Nov;46(5):823-7

Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mus.23464DOI Listing
November 2012

The absolute monocyte count is associated with overall survival in patients newly diagnosed with follicular lymphoma.

Leuk Lymphoma 2012 Apr 3;53(4):575-80. Epub 2012 Jan 3.

Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI 48109-5948, USA.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/10428194.2011.63
Publisher Site
http://dx.doi.org/10.3109/10428194.2011.637211DOI Listing
April 2012

Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma.

Clin Gastroenterol Hepatol 2010 Dec 17;8(12):1042-7. Epub 2010 Sep 17.

Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2010.09.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594736PMC
December 2010

Predicting survival for diffuse large B-cell lymphoma patients using baseline neutrophil/lymphocyte ratio.

Am J Hematol 2010 Nov;85(11):896-9

Division of Hematology/Department of Medicine, Mayo College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21849DOI Listing
November 2010

Composite hodgkin and non-hodgkin lymphoma of the mitral and aortic valves.

J Am Soc Echocardiogr 2010 Oct 7;23(10):1113.e5-7. Epub 2010 May 7.

Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.echo.2010.03.011DOI Listing
October 2010

Interleukin-15 affects patient survival through natural killer cell recovery after autologous hematopoietic stem cell transplantation for non-Hodgkin lymphomas.

Clin Dev Immunol 2010 18;2010:914945. Epub 2010 Apr 18.

Division of Hematology, Department of Medicine and Blood and Marrow Program, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2010/914945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855983PMC
July 2010

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma.

Am J Hematol 2010 May;85(5):320-4

Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21664DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420736PMC
May 2010

PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.

Mod Pathol 2010 Apr 29;23(4):593-602. Epub 2010 Jan 29.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2010.4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848697PMC
April 2010

New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma.

Biol Blood Marrow Transplant 2010 Mar 31;16(3):376-83. Epub 2009 Oct 31.

Division of Hematology/Department of Medicine, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.10.029DOI Listing
March 2010

Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma.

Am J Hematol 2009 Feb;84(2):93-7

Division of Hematology/Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.21337DOI Listing
February 2009